Search - tctmd.com

Displaying 341 - 360 of 388

Sort: Relevancy | Date

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Daily News

Complications Spiked, Then Fell, After Initial Introduction of Watchman LAA Closure Device

Todd Neale

October 12, 2017

Podcast

Episode 18: Top News of TCT 2016 Plus Anticoagulation in A-fib Patients

October 11, 2017

News Conference News PCR London Valves 2017

Pacemakers and Paravalvular Leak With Lotus: Updates From REPRISE III

Shelley Wood

September 27, 2017

News Opinion Editor's Corner ESC 2017

My Takeaways From ESC 2017: That Lovin’ Feeling? Barcelona Brings It Back

Shelley Wood

September 08, 2017

News Opinion Editor's Corner ESC 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

Shelley Wood

August 18, 2017

News Daily News

Permanent Pacemakers Post-TAVR Don’t Increase Adverse Event Risk: Meta-analysis

Ashley Lyles

August 08, 2017

Presentation LAA 2017

Pre-Procedural Imaging to Characterize the PFO: TTE, TEE, TCD

Presenter: Zahid Amin

July 22, 2017

Presentation LAA 2017

My 3 Most Challenging Transseptal Punctures in 5 Minutes

Presenter: Brian Whisenant

July 22, 2017

Presentation LAA 2017

Electrical/Ablation Approaches to AFib: Competitive or Complementary With LAA Closure?

Presenter: Vivek Y. Reddy

July 21, 2017

News Conference News EuroPCR 2017

EWOLUTION Analysis Backs LAA Closure in High-Risk Patients Taking DAPT, Not Warfarin, After Procedure

Michael O'Riordan

May 24, 2017

News Daily News

‘Reassuring’ Results for Watchman LAA Closure Device Seen in EWOLUTION Registry

Todd Neale

May 17, 2017

Presentation SCAI 2017

Results From The BRAVO 3 Randomized Trial

Presenter: Usman Baber

May 15, 2017

News Conference News SCAI 2017

New-Onset A-fib After TAVR Linked to Increased Risk of Early Stroke

L.A. McKeown

May 12, 2017

Presentation SWVS 2017

Cases: The Good, The Bad and The Ugly

Presenter: Michael J. Reardon

May 07, 2017

News Conference News ACC 2017

My Takeaways From ACC 2017: Even With a Sea Change, the Tide Takes Its Time

Shelley Wood

March 23, 2017

News Conference News ACC 2017

Add-on LAA Occlusion in Cardiac Surgery Cuts Thromboembolism Risk in A-fib Patients

L.A. McKeown

March 21, 2017

News Daily News

NOACs Seem to Perform Just Fine in Patients With A-fib and Most Types of Valvular Disease

Todd Neale

March 14, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2017

Shelley Wood

March 01, 2017

Advertisement

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Complications Spiked, Then Fell, After Initial Introduction of Watchman LAA Closure Device

Episode 18: Top News of TCT 2016 Plus Anticoagulation in A-fib Patients

Pacemakers and Paravalvular Leak With Lotus: Updates From REPRISE III

My Takeaways From ESC 2017: That Lovin’ Feeling? Barcelona Brings It Back

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

Permanent Pacemakers Post-TAVR Don’t Increase Adverse Event Risk: Meta-analysis

Pre-Procedural Imaging to Characterize the PFO: TTE, TEE, TCD

My 3 Most Challenging Transseptal Punctures in 5 Minutes

Electrical/Ablation Approaches to AFib: Competitive or Complementary With LAA Closure?

EWOLUTION Analysis Backs LAA Closure in High-Risk Patients Taking DAPT, Not Warfarin, After Procedure

‘Reassuring’ Results for Watchman LAA Closure Device Seen in EWOLUTION Registry

Results From The BRAVO 3 Randomized Trial

New-Onset A-fib After TAVR Linked to Increased Risk of Early Stroke

Cases: The Good, The Bad and The Ugly

My Takeaways From ACC 2017: Even With a Sea Change, the Tide Takes Its Time

Add-on LAA Occlusion in Cardiac Surgery Cuts Thromboembolism Risk in A-fib Patients

NOACs Seem to Perform Just Fine in Patients With A-fib and Most Types of Valvular Disease

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

TCTMD’s Top 10 Most Popular Stories for February 2017

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content